Author

Esperanza Caballero-González

Observed name: Esperanza Caballero-Gonzalez

Institution: Finlay Institute

Observed institution: Finlay Institute

OpenAlex ID: A5028691466

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

2022 · María Eugenia Toledo-Romaní, Mayra García-Carmenate, et al. · The Lancet Regional Health - Americas · 75

Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children

2022 · Rinaldo Puga-Gómez, Yariset Ricardo-Delgado, et al. · International Journal of Infectious Diseases · 33

Works count: 3

Citation count: 108

H-index: 2

I10-index: 2